Protein synthesis in resting and stimulated human lymphocytes

The ribosomal profiles in lysates from resting and phytohemagglutinin stimulated human lymphocytes have been analyzed by sucrose gradient centrifugation. The percentage of polyribosomes increased during lymphocyte transformation reaching a maximal value of 60 to 70% of the total ribosomes after 72 h...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Burrone, O., Algranati, I.D.
Formato:	JOUR
Materias:	phytohemagglutinin in vitro study lymphocyte activation normal human polysome protein synthesis theoretical study Antibiotics Cells, Cultured Chloramphenicol Cycloheximide DNA Human Kinetics Lectins Lymphocyte Activation Lymphocytes Magnesium Poly U Proteins Puromycin Ribosomes RNA, Messenger Translation, Genetic
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_03008177_v16_n2-3_p105_Burrone
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Protein synthesis in resting and stimulated human lymphocytes
por: Burrone, Oscar R., et al.
Publicado: (1977)

Protein phosphokinase activities of resting and proliferating human lymphocytes. Changes upon phytohemagglutinin stimulation and in acute lymphoblastic leukemic cells
Publicado: (1976)

Protein phosphokinase activities of resting and proliferating human lymphocytes. Changes upon phytohemagglutinin stimulation and in acute lymphoblastic leukemic cells
por: Horenstein, A., et al.

Ribosome-bound translational inhibitor in resting human lymphocytes
por: Burrone, O.R., et al.

Inhibition of polypeptide synthesis by a factor isolated from ribosomes of resting human lymphocytes. Studies on the mechanism of action
por: Ferrer, M., et al.

Ribosome-bound translational inhibitor in resting human lymphocytes
por: Burrone, Oscar R., et al.
Publicado: (1979)

Inhibition of polypeptide synthesis by a factor isolated from ribosomes of resting human lymphocytes. Studies on the mechanism of action
por: Ferrer, Marcela María, et al.
Publicado: (1980)

DNA polymerases from non stimulated and phytohemagglutinin stimulated normal human lymphocytes
Publicado: (1974)

DNA polymerases from non stimulated and phytohemagglutinin stimulated normal human lymphocytes
por: Fridlender, B., et al.

Effect of colchicine, vinblastine and cytochalasin B on human lymphocyte transformation by phytohemagglutinin
Publicado: (1974)

Effect of colchicine, vinblastine and cytochalasin B on human lymphocyte transformation by phytohemagglutinin
por: Medrano, E., et al.

Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes
Publicado: (2003)

Insulin-like growth factor-1 receptor regulation in activated human T lymphocytes
por: Segretin, M.E., et al.

Antagonistic effect of insulin and cortisol on stimulated lymphocytes
Publicado: (1986)

Antagonistic effect of insulin and cortisol on stimulated lymphocytes
por: Castillo, M.B., et al.

Polypeptide Synthesis in Toluene‐Treated Lymphocytes
por: BURRONE, O.R.

Polypeptide Synthesis in Toluene‐Treated Lymphocytes
Publicado: (1978)

Immunomodulatory activity of plasmatic substances.
por: Lauricella, Ana María, et al.
Publicado: (1991)

Immunomodulatory activity of plasmatic substances.
por: Lauricella, A.M., et al.

Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin
Publicado: (1989)

Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin
por: Roldan, A., et al.

Synthesis of Phosphatidyl‐dCMP in Human Lymphocytes and Its Enhancement by Chlorpromazine
Publicado: (1981)

Synthesis of Phosphatidyl‐dCMP in Human Lymphocytes and Its Enhancement by Chlorpromazine
por: MEDRANO, E., et al.

TRH receptor on immune cells:In vitro and in Vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH
por: Labeur, Marta Susana
Publicado: (1995)

TRH receptor on immune cells:In vitro and in Vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH
por: Raiden, S., et al.

Chromosomal Sensitivity of Human-Lymphocytes to Bleomycin - Influence of Antioxidant Enzyme-Activities in Whole-Blood and Different Blood Fractions
por: Bolzan, Alejandro D., et al.
Publicado: (1992)

Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
Publicado: (2008)

Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis
por: Jurado, J.O., et al.

Effect of histamine on human lymphocyte aggregation
Publicado: (1991)

Effect of histamine on human lymphocyte aggregation
por: Maugeri, N., et al.

Dok-4 is a novel negative regulator of T cell activation
Publicado: (2009)

Dok-4 is a novel negative regulator of T cell activation
por: Gérard, A., et al.

Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: Mechanisms and biomedical applications
por: Mascanfroni, I.D., et al.

Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses
Publicado: (2017)

Restimulation-induced T-cell death through NTB-A/SAP signaling pathway is impaired in tuberculosis patients with depressed immune responses
por: Hernández Del Pino, R.E., et al.

Early effects of insulin-like growth factor-1 in activated human T lymphocytes
Publicado: (2001)

Early effects of insulin-like growth factor-1 in activated human T lymphocytes
por: Brocardo, M.G., et al.

Endogenous lectins shape the function of dendritic cells and tailor adaptive immunity: Mechanisms and biomedical applications
por: Croci Russo, Diego Omar, et al.
Publicado: (2011)

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
por: Almejún, María Belén, et al.
Publicado: (2017)

The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients
por: Colado, A., et al.